More than 81 million people live with heart disease in the United States.Many of them will benefit from interventional procedures developed or refined by the Cardiovascular Research Foundation (CRF). Still others will have their lives transformed by technologies that are only now emerging and being studied and perfected here before becoming available to patients. Since its inception in 1991, CRF has played a major role in realizing dramatic improvements in the lives of patients by establishing the safe use of new technologies, drugs, and therapies in interventional cardiovascular medicine.
Cardiovascular Research Foundation Complex PCI: Left Main and CTO Summit
Leading practitioners of percutaneous coronary intervention must become experts at recanalizing chronic total occlusions, and with advanced techniques, success rates greater than 90% may be obtained. Moreover, stenting of the unprotected left main coronary artery has emerged as a viable alternative to surgery in selected patients but requires a special skill set and understanding of anatomy, imaging, hemodynamic support, and adjunctive devices. Bringing together leaders in the fields of chronic total occlusions (CTOs) and percutaneous left main intervention, the Complex PCI: Left Main and CTO Summit will be held from the heart of New York City.
These sessions will emphasize both advanced techniques and evidence-based medicine, with a heavy reliance on live case transmissions featuring the world’s leading experts in left main and CTO stenting. Topics to be covered include:
- When and why to open a CTO
- Left main PCI vs. CABG: Patient selection
- CTO angioplasty: Antegrade vs. retrograde approaches; wire and device selection, and essential techniques and tips
- Basic and advanced imaging and physiologic lesion assessment to improve procedural results and late outcomes
- Pharmacology essentials
- Minimizing and managing complications